MYC and cancer: Our recent study established a DOX‐inducible MYC‐mutant‐MYC‐KO system in cancer cell line, which enables the accurate profiling of transcriptional consequences of MYC's loss‐of‐function (LOF) on its RNA and DNA binding ability [15].